Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 21, 2020

SELL
$87.74 - $152.74 $120,905 - $210,475
-1,378 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$117.65 - $153.73 $162,121 - $211,839
1,378 New
1,378 $206,000
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $188,521 - $215,719
-1,506 Closed
0 $0
Q2 2019

Jul 30, 2019

SELL
$125.55 - $144.48 $11,425 - $13,147
-91 Reduced 5.7%
1,506 $214,000
Q1 2019

May 07, 2019

BUY
$121.81 - $142.95 $194,530 - $228,291
1,597 New
1,597 $228,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.68B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.